Sarcopenia Treatment Market Size (2024 - 2029)

Sarcopenia Treatment Market Analysis

The Sarcopenia Treatment Market size is estimated at USD 3.07 billion in 2024, and is expected to reach USD 4.02 billion by 2029, growing at a CAGR of 4.48% during the forecast period (2024-2029).

Factors such as the rise in the geriatric population and the increase in malnutrition, coupled with vitamin deficiency globally, are expected to increase the need for sarcopenia treatment, fueling the market growth over the study period. For instance, according to a study published in August 2022 in Nutrients Journal, older people had a higher risk of developing Sarcopenia, emphasizing the need for proper treatment and nutrition intake. Moreover, according to the World Population Prospects 2022 report by the United Nations, the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. As the senior population is more prone to acquiring muscle issues due to their age, the demand for sarcopenia treatment is expected to increase with the aging population, contributing to market growth over the study period.

Additionally, an increase in research studies and pipeline assets by the key players focusing on sarcopenia treatment is expected to augment the market growth over the study period. For instance, Research Square's article published in February 2022 highlighted the association of Sarcopenia with vitamin D, protein, and calcium intake. Among these nutrients, calcium has the most significant impact. Also, an article published by the Examine in January 2022 examined the association between vitamin B12 and muscle health in older adults. In this study, the investigators assessed several markers of muscle health, including appendicular (legs and arms) skeletal muscle mass, handgrip strength, and performance on a physical test battery. The study compared the vitamin B12 insufficiency associated with low appendicular skeletal muscle mass. Hence, the increased adoption of Vitamin B12, Calcium and Vitamin D among older patients in treating Sarcopenia will likely boost the market growth.

Furthermore, a low-quality diet and muscle weakness are significant factors contributing to Sarcopenia. Increasing the uptake of proper nutrition and vitamins may significantly reduce the risk of Sarcopenia. 

According to an article published by Frontiers in Endocrinology in June 2022, vitamin D supplementation improved handgrip strength in postmenopausal women. The supplement did not improve mobility but enhanced muscle strength, particularly in postmenopausal women over 60 without calcium supplementation or whose baseline vitamin D is >75 nmol/L (30 ng/ml). Hence, such research studies depicting the importance of nutritional intake in treating Sarcopenia are expected to drive market growth over the forecast period.

Thus, due to the increase in the geriatric population, the rise in research studies to develop sarcopenia treatment products, and the surge in advantages offered by sarcopenia treatment products, the market studied is expected to witness significant growth over the study period. However, the non-availability of new drugs will hinder the market's growth over the forecast period.

Sarcopenia Treatment Industry Segmentation

Sarcopenia is a term used to describe the loss of muscle mass, strength, and function associated with aging. Currently, there are no FDA-approved medications for the treatment of sarcopenia. The effects of exercise and nutritional supplementation on patients with sarcopenia have been examined in numerous studies. The sarcopenia treatment market is segmented by treatment type, distribution channel, and geography. Based on the treatment type, the market is segmented into protein supplements, vitamin B12 Supplements, vitamin D and calcium supplements, and other treatment types. Other treatment types include cell therapy, gene therapy, and hormone therapy. By distribution channel, the market is segmented by hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. Other distribution channels include hypermarkets, supermarkets, clinic pharmacies, and drug stores. The report also covers the market sizes and forecasts for the sarcopenia treatment market in major countries across different regions.

For each segment, the market size is provided in terms of value (USD).